Veeva Systems (VEEV) is back in focus after AOP Health chose its Development, Quality, Commercial, and Data Clouds to run integrated rare disease and intensive care programs, connecting research with ...

It's off to a pretty decent start.

Shares of Veeva Systems (VEEV) have gained 2.7% over the past four weeks to close the last trading session at $178.88, but there could still be a solid upside left in the stock if short-term price ...

Recently, Zacks.com users have been paying close attention to Veeva (VEEV). This makes it worthwhile to examine what the stock has in store.

In the latest quarter, 8 analysts provided ratings for Veeva Systems (NYSE: VEEV ), showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview of their recent ...

Veeva Systems has seen its stock go from a 5% gain this morning to a 9% drop later in the day. This comes on the heels of the company's earnings release, which beat on both earnings and revenue -- and ...

In conversation with Fierce Pharma, Anthony Billinger, senior director of Compass Strategy at Veeva Systems, sheds light on the rapidly evolving world of commercial data in life sciences—and why the ...

Veeva is paying approximately $100 million to acquire Ostro, according to this week’s announcement, comprising a combination ...